The ARV of any Prize is subject to change based
on current market conditions at time of Prize fulfillment, the time of travel, and the distance between departure location and the PlayStation Experience location.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses
on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect
on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic
conditions on the business aircraft
market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic
conditions in the industries and
markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact
on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact
on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns
on pension plan assets and the impact of future discount rate changes
on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco
on favorable terms or
at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted
on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence
on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments
on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest
on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign
current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required
on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings;
market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and
current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other
market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact
on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
These risks include, in no particular order, the following: the trends toward more high - definition,
on - demand and anytime, anywhere video will not continue to develop
at its
current pace or will expire; the possibility that our products will not generate sales that are commensurate with our expectations or that our cost of revenue or operating expenses may exceed our expectations; the mix of products and services sold in various geographies and the effect it has
on gross margins; delays or decreases in capital spending in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact of general economic
conditions on our sales and operations; our ability to develop new and enhanced products in a timely manner and
market acceptance of our new or existing products; losses of one or more key customers; risks associated with our international operations; exchange rate fluctuations of the currencies in which we conduct business; risks associated with our CableOS ™ and VOS ™ product solutions; dependence
on market acceptance of various types of broadband services,
on the adoption of new broadband technologies and
on broadband industry trends; inventory management; the lack of timely availability of parts or raw materials necessary to produce our products; the impact of increases in the prices of raw materials and oil; the effect of competition,
on both revenue and gross margins; difficulties associated with rapid technological changes in our
markets; risks associated with unpredictable sales cycles; our dependence
on contract manufacturers and sole or limited source suppliers; and the effect
on our business of natural disasters.
Van Biema's book also includes a lengthy chapter
on Lou Simpson, a former GEICO investment manager and eventual successor to Warren Buffett
at Berkshire Hathaway, who is famous for saying, «The stock
market is like the weather in that if you don't like the
current conditions all you have to do is wait awhile.»
At a certain point, the
market (such as in its
current condition) becomes «flipped» where an intelligent affiliate / web owner would instead focus
on link selling to webmasters focused
on competitive research, instead of trying to recreate a website in the same system and trying to rank with significantly more risk.
Don't be surprised if a vehicle you are looking
at changes in price based
on current market conditions!
According to Maurizio Reggiani (head of research and development
at Lamborghini) the
current market conditions are not in favor to put an additional model in the line up, hence the magnificent four door Estoque that was unveiled
at the 2008 Paris Auto Show will not be seen
on the road any time soon.
An RC settlement will buy new items to replace the damaged ones regardless of
current market value, but an ACV settlement will depreciate the value of the damaged items based
on age and
condition at the time of loss.
The views are subject to change
at any time based
on market or other
conditions and are
current as of the date indicated
on the materials.
At our seminars, you'll gain insight into the home buying and selling process,
current market conditions, tips
on working with a real estate agent, Tower's mortgage financing options and more.
At the end of the index term, your client benefits from competitive renewal caps and fixed interest crediting rates based
on the
current interest rate environment and
current market conditions.
Recordkeeping fees for jumbo plans have declined significantly in recent years due to increased technological efficiency, competition, and increased attention to fees by sponsors of other plans such that fees that may have been reasonable
at one time may have become excessive based
on current market conditions.
Van Biema's book also includes a lengthy chapter
on Lou Simpson, a former GEICO investment manager and eventual successor to Warren Buffett
at Berkshire Hathaway, who is famous for saying, «The stock
market is like the weather in that if you don't like the
current conditions all you have to do is wait awhile.»
At the end of the guarantee period, your client benefits from competitive renewal rates based
on the
current interest - rate environment and
current market conditions.
«We believe that the repurchase of our common stock
at this time is an effective use of our capital based
on current market conditions and the price of our stock relative to the Company's balance sheet and enterprise value.»
At the end of the index term, your client benefits from competitive renewal rates based
on the
current interest - rate environment and
current market conditions.
Live weekly webinars with stock
market Coach Jason Brown with an emphasis
on current market conditions, a look
at all the major indexes, such as the S&P 500, DOW, NASDQ, and a deep dive into
current trading opportunities and option strategies for any
market condition.
the size and nature of the Fund's holdings; (iv) the discount from
market value of unrestricted securities of the same class
at the time of purchase and subsequent thereto; (v) information as to any transactions or offers with respect to the security; (vi) the nature and duration of restrictions
on disposition of the security and the existence of any registration rights; (vii) how the yield of the security compares to similar securities of companies of similar or equal creditworthiness; (viii) the level of recent trades of similar or comparable securities; (ix) the liquidity characteristics of the security; (x)
current market conditions; and (xi) the
market value of any securities into which the security is convertible or exchangeable.
Among her recent co-edited publications are Contemporary Art and Its Commercial
Markets: A Report
on Current Conditions and Future Scenarios, Performing the Curatorial: With and Beyond Art, and Art and the F Word: Reflections
on the Browning of Europe, all
at Sternberg Press.
109 speakers and more than 800 attendees discussed
current industry topics and shed light
on the
conditions surrounding technological,
market and political developments
at the accompanying conference.
109 distinguished speakers and 800 + attendees discussed
current industry topics and shed light
on the
conditions surrounding technological,
market and political developments
at the accompanying conference.
• Prepare documents such as representation contracts, purchase agreements, closing statements, leases, and deeds • Accompany buyers during visits to and inspections of property, advising them
on the suitability and value of the homes they are visiting based
on current market conditions • Conduct quarterly seminars and training sessions for sales agents to improve sales techniques • Advise sellers
on how to make homes more appealing to potential buyers increasing average selling prices by 16 % from initial appraisals • Evaluate mortgage options helping clients obtain financing
at the best rates and terms
«From the owner perspective, we have seen a high potential of sales, as owners have made it through the depression and have decided to capitalize
on current market conditions,» says Devin B. White, a vice president
at CBRE in Miami.
Jensen says: «You really have to look
at the comps in today's
current market conditions and write a competitive offer based
on that.
Note: Borrowers are not eligible for a new FHA - insured mortgage if they pursued a short - sale agreement
on their principal residence simply to take advantage of declining
market conditions to purchase a similar or superior property within a reasonable commuting distance
at a reduced price, as compared with
current market value.
Focused
on the theme of navigating
current market conditions and anticipating future innovations, the 2017 NIC Fall Conference brought together a record number of 3,000 industry leaders and stakeholders
at the Sheraton Grand Chicago, Sept. 26 - 28.